top of page
The latest from NuvOx
Search
NuvOx Announces Glioblastoma Patient Treatment for Phase IIb RESTORE Trial
Tucson, AZ, May 30, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to treat...
Jun 7, 2023
NuvOx Receives SPAN Grant
NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with Reperfusion Tucson, AZ, ...
Apr 19, 2023
NuvOx Newly Issued US Patent
The issued patent has claims for methods of use of DDFPe for stroke treatment.
Mar 5, 2023
Oct 11, 2022
NuvOx Pharma Announces Issuance of a New Patent
Award of this patent broadens NuvOx’s extensive patent portfolio of perfluorocarbon-based therapeutic formulations to reverse hypoxia.
May 19, 2022
bottom of page